Patent
HLA-A2 tumor associated antigen peptides and compositions (US Patent 9913884)
OSE Pharma International SA · Granted Mar 13, 2018 · Filed Jun 28, 2016
Patent number: 9913884 Kind code: B2 Granted: 2018-03-13 Filed: 2016-06-28 Inventors: John D. Fikes (Utrecht, NL); Glenn Ishioka (San Diego, CA, US); Alessandro Sette (La Jolla, CA, US); Robert W. Chesnut (Cardiff-by-the-Sea, CA, US) Assignees: OSE Pharma International SA (Geneva, CH)
Abstract
A peptide or composition comprising at least one HLA-A2 epitope or analog from CEA, HER2/neu, MAGE2, MAGE3, or p53.
Claims
- A method of inhibiting cancer in a patient comprising administering a composition
Showing a preview — retrieve the full document via the Exa API.
Powered by the Exa API